Extension Study Evaluating Etanercept in Ankylosing Spondylitis
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the health care resource utilization and
work status of patients with ankylosing spondylitis undergoing treatment with etanercept by
comparing study evaluations with the baseline evaluations in the ASCEND
(0881A3-402)(NCT00247962) study.